Poland· PL-100516890
Lorinden N
A flumetason und antibiotika product containing flumetasoni pivalas + neomycini sulfas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Flumetason und antibiotika is registered in 3 of 19 countries.
Countries holding a registration under ATC D07CB05 (flumetason und antibiotika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 1 of them publish a price we can compare per daily dose
Flumetason und antibiotika · ATC D07CB05
3 / 19 countries
- Canada
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Flumetasoni pivalas + Neomycini sulfas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D07CB05
- ATC class
- Flumetason und Antibiotika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991570750
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D07CB05
Flumetason und antibiotika, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/22152a97-014e-48ef-b131-2e98214c1d11 GET /v1/drugs/22152a97-014e-48ef-b131-2e98214c1d11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "(0,2 mg + 5 mg)/g",
"packaging": "05909991570750 ¦ Rp ¦ 161483\n1 tuba 15 g",
"substance": "Flumetasoni pivalas 0.2 mg + Neomycini sulfas 5 mg",
"common_name": "Flumetasoni pivalas + Neomycini sulfas",
"pl_product_id": "100516890",
"pozwolenie_nr": "144/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-04-15"
}See everything about flumetason und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.